Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > RE :TFSA

<< Previous

Bullboard Posts

Next >>

Comment by FredTheVoiceon Jan 05, 2022 4:53pm

147 Views

Post# 34286989

RE:RE:RE:RE:RE:RE :TFSA

Muslix you remember when we were talking about meeting with An-ALIAS in Montreal ? Peel Pub ? I know, aint possible with all the mesures, and....all that sh%?&*t,

But lets add Stephane to the board of beer directors.

All right ?

Cheers,

FTV.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China